An effective detection and response capability is essential for monitoring key assets, containing threats early and eradicating them. However, due to the current disparate nature of potential attack vectors within an organization, affording the wide range of sensors necessary can be a challenge as well as the worry of the disruption of critical services. Yet, without robust detection and response processes, businesses are left vulnerable.
Biotech companies face an era of opportunities and challenges as data volumes explode and technology rapidly evolves. The pressure to enhance collaboration and efficiently manage data is immense. This article explores how innovative biotechs leverage platforms like Egnyte to transform their operations.
Cisco has released an advisory, acknowledging active exploitation of a previously unknown vulnerability, which is tracked as CVE-2023-20198, in the web UI feature of Cisco IOS XE Software when exposed to the internet or to untrusted networks. This vulnerability allows a remote, unauthenticated attacker to create an account on an affected system with privilege level 15 access, which is the highest level of access.
In an age characterized by digital transformation, APIs serve as the backbone of modern applications, enabling diverse systems to communicate and share data seamlessly. This widespread API adoption, however, exposes organizations to a considerable attack surface, inviting the attention of cyber adversaries searching for vulnerabilities to exploit.